Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-24 @ 10:40 PM
NCT ID:
NCT02611635
Eligibility Criteria:
Inclusion Criteria:
Inclusion criteria for AF patients in both the NOAC and the VKA groups:
* Patients with a confirmed diagnosis of nonvalvular atrial fibrillation (persistent, paroxysmal, permanent),
* Age of at least 18 years at time of study inclusion,
* Generally willingness (informed consent) and ability to fill out a survey on satisfaction with treatment and quality of life, and to conduct a structured phone interview (approx. 20 - 30 min) in Swedish language.
Additional inclusion criterion for Group 1 (NOAC):
* Continuous anticoagulation with either Apixaban, or Dabigatran or Rivaroxaban for prevention of Stroke \& systemic embolism for at least the previous 3 months.
Additional inclusion criterion for Group 2 (VKA):
* Continuous anticoagulation with a VKA for prevention of Stroke \& systemic embolism for at least the previous 3 months.
Exclusion Criteria:
Exclusion criteria for both groups:
* Participation in another
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02611635
Study Brief:
Protocol Section:
NCT02611635